Accuryn Stock
Accuryn, developed by Retia Medical, provides advanced hemodynamic monitoring solutions for critical care patients. Its system offers continuous and precise cardiac output measurements using proprietary algorithms to enhance patient management.
For more Accuryn stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Sanjay Banerjee Chief Executive Officer |
| Rich Keenan Chief Product Officer |
